Stay updated on CTX110 in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX110 in B-Cell Malignancies Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T13:15:25.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T19:09:13.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:21:38.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.4%
    Check dated 2025-02-03T05:06:43.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T19:26:06.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The website has updated its intervention details, including a new termination status and a follow-up study date, while removing previous intervention types and estimated dates.
    Difference
    3%
    Check dated 2025-01-12T16:05:42.000Z thumbnail image

Stay in the know with updates to CTX110 in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.